Du, Shanshan
Zeugolis, Dimitrios I.
O’Brien, Timothy
Funding for this research was provided by:
Science Foundation Ireland (13/RC/2073_P2)
Article History
Received: 19 January 2022
Accepted: 4 August 2022
First Online: 20 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: TOB is a director and equity holder in Orbsen Therapeutics.